TMS

tms-logo

TMS provides software development and system support services.

#SimilarOrganizations #Website #More

TMS

Industry:
Service Industry Software Technical Support

Founded:
1989-10-01

Address:
Sumida, Tokyo, Japan

Country:
Japan

Website Url:
http://www.tms-corp.co.jp

Total Employee:
1+

Status:
Active

Contact:
03-5610-2571

Technology used in webpage:
SPF Apache JPRS


Similar Organizations

not_available_image

Brains

Brains provides software development and information system support services.

cosmos-more-logo

Cosmos More

Cosmos More provides workplace development and outsourcing services.

Official Site Inspections

http://www.tms-corp.co.jp

  • Host name: swqxw124.secure.ne.jp
  • IP address: 115.146.3.124
  • Location: Tokyo Japan
  • Latitude: 35.6882
  • Longitude: 139.7532
  • Timezone: Asia/Tokyo
  • Postal: 102-0082

Loading ...

More informations about "TMS"

HOME | TMS Co., Ltd. - tms-japan.co.jp

Jul 17, 2024 TMS Co., Ltd. to participate in BIO Asia-Taiwan 2024 Investment Summit (98KB) Jul 12, 2024 Non-consolidated Financial Results for the Three Months Ended May 31, 2024 [Japanese GAAP] (273KB)See details»

TMS - Crunchbase Company Profile & Funding

TMS is a Tokyo-based clinical-stage biotech company that unlocks fungus-derived SMTP small molecule compound group. SMTPs have novel dual mode of action, both thrombolytic and anti-inflammatory. The lead compound TMS-007 …See details»

Investor Relations | TMS Co., Ltd. - tms-japan.co.jp

Nov 15, 2024 TMS Co., Ltd. CEO Takuro Wakabayashi Interviewed on US Internet News Media 'Biotech TV’ (179KB) Nov 12, 2024 Notice Concerning the Patent for which TMS is granted …See details»

TMS - Crunchbase Company Profile & Funding

TMS provides software development and system support services. Sumida, Tokyo, Japan; 1-10; Private; tms-corp.co.jp/ 3,323,884; HighlightsSee details»

Developing revolutionary drugs for diseases without …

Initial research efforts were concentrated on TMS-007, an SMTP compound. TMS-007, which dissolves blood clots and controls inflammation, is anticipated to be highly effective for treating acute ischemic strokes. TMS stepped up its …See details»

Company | TMS Co., Ltd. - tms-japan.co.jp

Cookie Policy. We use cookies to provide you with a better browsing experience. Please confirm that you agree to our use of cookies by clicking Yes.See details»

4891 | TMS Co. Ltd. Profile - MarketWatch

TMS Co., Ltd. engages in the research and development of pharmaceutical products and medical devices. It focuses on a family of compounds called Stachybotrys microspora triprenyl phenol …See details»

TMS Co., Ltd. (4891.T) Company Profile & Facts - Yahoo Finance

See the company profile for TMS Co., Ltd. (4891.T) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»

4891.JP | TMS Co. Ltd. Company Profile & Executives - WSJ

Company profile for TMS Co. Ltd. including key executives, insider trading, ownership, revenue and average growth rates. View detailed 4891.JP description & address.See details»

TMS Co Ltd, 4891:TYO profile - FT.com - Financial Times

5 days ago TMS-008, a follow-on product in the pipeline, is being developed for various inflammatory diseases and is currently undergoing pre-clinical studies. Revenue in JPY (TTM) …See details»

TMS Co Ltd - Company Profile and News - Bloomberg Markets

TMS Co., Ltd. develops biotechnology products. The Company provides research and development of drug products quasi drugs, drug substances, and others. TMS also offers …See details»

TMS CO., LTD. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for TMS CO., LTD. of FUCHU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»

TMS Co., Ltd. Stock (4891) - Quote Japan Exchange- MarketScreener

2 days ago TMS Co., Ltd. Stock Equities 4891 JP3544960002 Biotechnology & Medical Research Market Closed - Japan Exchange. Other stock markets. 01:30:00 2024-12-02 am …See details»

Board of Directors | About Us | TMS Co., Ltd. - tms-japan.co.jp

Dr. Reiko Namikawa has served on TMS’s board of directors since 2021. She is an MD, PhD scientist with over 30 years of experience in the biotech/pharma industry in the US. She works …See details»

TMS Co Ltd, 4891:TYO summary - FT.com - Financial Times

Nov 27, 2024 TMS Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and marketing of pharmaceuticals. The Company conducts …See details»

TMS Company Profile - Office Locations, Competitors, Revenue

TMS (Transcranial Magnetic Stimulator) Market ($2.02Bn by 2028) Growth Forecast at 8.8% CAGR During (2021-2028) - COVID-19 Impact and Global Analysis by …See details»

4891 | TMS Co. Ltd. Stock Overview (Japan: Tokyo) | Barron's

Complete TMS Co. Ltd. stock information by Barron's. View real-time 4891 stock price and news, along with industry-best analysis.See details»

TMS Co Ltd (4891) Stock Price & News - Google Finance

Get the latest TMS Co Ltd (4891) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»

tms - Toyko - Marketing, Sourcing and Technology Company

Tms Tokyo. Osaki MT Building 14th Floor 5-9-11 Kita-Shinagawa Shinagawa-ku, Tokyo 141-0001 Japan +81 3 6300 7002. Trending posts. tms Munich wins the Silver Effie for MONOPOLY at …See details»

Nemetschek Brand Maxon Strengthens Business in Japan

Jan 19, 2021 The Nemetschek Group today announced that its subsidiary Maxon, headquartered in Germany, has acquired 100% of the business segment of its Japanese …See details»

linkstock.net © 2022. All rights reserved